Clinical Trial Update: Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the safety and efficacy of Obatoclax Mesylate (GX15-070MS) in patients with myelofibrosis (myelofibrosis with myeloid metaplasia) has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Obatoclax Mesylate (obatoclax mesylate)

Snippet

Sponsor: Gemin X | Conditions: Myelofibrosis | Phase 2 | Status: COMPLETED